Advancing immunotherapy for life-threatening prostate cancer

Restoring tumor-specific immunity is a treatment strategy that has worked well, but only against some cancers. Research led by OHSU oncologist Julie Graff, M.D., revived hope that the approach may...

Cancer genome study reveals big window for early detection

Tell-tale DNA errors arise years before tumors become dangerous. For cancers that can’t currently be detected early, a new discovery suggests there may be a large window of time in which to look...

From old samples, new breast cancer answers

OHSU scientists have shown how it’s possible to obtain detailed views of breast cancer gene activity from preserved tumor samples more than a decade old. The researchers say their RNA sequencing...

Knight Cancer Institute signal achievements of 2019

From basic research, to patient care, to impact in the community, the OHSU Knight Cancer Institute has a mission to end cancer as we know it. Here’s a look back at a year of...

Unraveling early events in a life-threatening leukemia

Cancer scientists reveal the first direct evidence that leukemia development depends on the order in which mutations occur. Acute myeloid leukemia, or AML, is the most common blood cancer in adults...

Study overturns basic tenet in leukemia biology

Scientists thought they understood the steps leading to acute myeloid leukemia. But one of the basic tenets in that understanding turns out to be unsound, according to researchers at the OHSU Knight...

A new prescription for cancer: Exercise

Updated guidance details how physical activity, tailored to the individual, can reduce side effects and improve quality of life. “Take it easy” and “don’t overexert yourself” were common...